Literature DB >> 27832986

CD32b expression is down-regulated on double-negative memory B cells in patients with Hashimoto's thyroiditis.

Yalei Liu1, Yan Gong2, Chenxue Qu3, Yang Zhang4, Ran You5, Nan Yu6, Guizhi Lu7, Youyuan Huang8, Hong Zhang9, Ying Gao10, Yanming Gao11, Xiaohui Guo12.   

Abstract

Inhibitory CD32b receptors on B cells are critical for humoral immunity. The humoral response plays a role in the pathogenesis of Hashimoto's thyroiditis (HT). This study aimed to investigate B cell subset distribution and CD32b expression within these subsets in HT patients. B cell subset distribution and CD32b expression were analyzed in 60 HT patients and 21 healthy donors. Subset distribution and CD32b expression following stimulation with α-Ig and α-CD40 were also assessed. The percentage of double-negative (DN) memory cells was increased in the HT patients, while the expression level of CD32b on DN memory cells was decreased. Redistribution of B cell subsets was detected in response to stimulation with α-Ig. In addition, the expression level of CD32b was reduced following α-CD40 stimulation. These results suggest that abnormal B cell subset distribution and decreased CD32b expression on DN memory cells might be involved in the pathogenesis of HT.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  B cell subsets; CD32b; Double-negative memory B cells; Hashimoto's thyroiditis

Mesh:

Substances:

Year:  2016        PMID: 27832986     DOI: 10.1016/j.mce.2016.11.004

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  3 in total

1.  FcγRIIb Expression Is Decreased on Naive and Marginal Zone-Like B Cells From Females With Multiple Sclerosis.

Authors:  Stephanie Trend; Jonatan Leffler; Ingrid Teige; Björn Frendéus; Allan G Kermode; Martyn A French; Prue H Hart
Journal:  Front Immunol       Date:  2021-01-11       Impact factor: 7.561

2.  Specific Induction of Double Negative B Cells During Protective and Pathogenic Immune Responses.

Authors:  Christoph Ruschil; Gisela Gabernet; Gildas Lepennetier; Simon Heumos; Miriam Kaminski; Zsuzsanna Hracsko; Martin Irmler; Johannes Beckers; Ulf Ziemann; Sven Nahnsen; Gregory P Owens; Jeffrey L Bennett; Bernhard Hemmer; Markus C Kowarik
Journal:  Front Immunol       Date:  2020-12-18       Impact factor: 7.561

Review 3.  Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.

Authors:  Sanae Ben Mkaddem; Marc Benhamou; Renato C Monteiro
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.